相似文献
1
Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.
Immunology. 1980 Sep;41(1):59-66.
2
Murine amyloid protein AA in casein-induced experimental amyloidosis.
Lab Invest. 1977 Apr;36(4):420-7.
3
Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis.
J Immunol. 1975 Jun;114(6):1785-91.
4
Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
Lab Invest. 1985 Oct;53(4):453-63.
5
Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
Clin Exp Immunol. 1986 Dec;66(3):691-700.
6
7
Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique.
J Pathol. 1980 Dec;132(4):343-8. doi: 10.1002/path.1711320405.
8
Further characterization of amyloid-enhancing factor.
Lab Invest. 1982 Aug;47(2):139-46.
9
Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
J Immunol. 1980 Feb;124(2):495-9.
10
Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
Lab Invest. 1996 Jan;74(1):259-64.
引用本文的文献
1
Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice.
PLoS One. 2021 Jan 22;16(1):e0245924. doi: 10.1371/journal.pone.0245924. eCollection 2021.
2
Amyloid P-component is a constituent of normal human glomerular basement membrane.
J Exp Med. 1980 Nov 1;152(5):1162-74. doi: 10.1084/jem.152.5.1162.
3
The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis.
Clin Exp Immunol. 1984 Sep;57(3):657-62.
4
Acute phase serum proteins in syngeneic and allogeneic mouse pregnancy.
Clin Exp Immunol. 1983 Jul;53(1):225-32.
5
Mouse hepatocyte synthesis and induction of the acute phase reactant: serum amyloid P-component.
In Vitro. 1984 Jun;20(6):505-11. doi: 10.1007/BF02619624.
6
Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.
Clin Exp Immunol. 1985 Jan;59(1):235-42.
7
Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
Clin Exp Immunol. 1986 Dec;66(3):691-700.
8
Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Clin Exp Immunol. 1986 Dec;66(3):701-8.
本文引用的文献
1
EXPERIMENTAL AMYLOIDOSIS: STUDIES WITH A MODIFIED CASEIN METHOD, CASEIN HYDROLYSATE AND GELATIN.
Am J Pathol. 1965 Jul;47(1):159-71.
2
IMMUNOLOGIC STUDIES ON A PROTEIN EXTRACTED FROM HUMAN SECONDARY AMYLOID.
N Engl J Med. 1965 Jul 15;273:143-6. doi: 10.1056/NEJM196507152730306.
3
4
Experimental amyloidosis. Role of antigenicity and rapid induction.
Am J Pathol. 1966 Jun;48(6):1013-25.
5
The ultrastructure of human amyloid as revealed by the negative staining technique.
J Ultrastruct Res. 1966 Mar;14(5):449-59. doi: 10.1016/s0022-5320(66)80075-8.
6
Immunofluorescence counterstains.
J Histochem Cytochem. 1974 Oct;22(10):962-6. doi: 10.1177/22.10.962.
7
Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit.
J Exp Med. 1978 Aug 1;148(2):466-77. doi: 10.1084/jem.148.2.466.
8
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.
Clin Exp Immunol. 1978 Apr;32(1):119-24.
9
Isolation of serum amyloid P-component (protein SAP) in the mouse.
Immunology. 1979 Jul;37(3):637-41.
10
The amyloid P-component (protein AP): an integral part of the amyloid substance?
Scand J Immunol. 1979;10(1):55-60. doi: 10.1111/j.1365-3083.1979.tb01334.x.
Zotero 插件
